4D Path is a provider of an end-to-end statistical physics and tumor biology tool designed to universally detect any cancer and its subtypes. The company's AI-driven solution provides unprecedented depth and breadth in cancer diagnosis and precision medicine, providing customers with an integrated clinical diagnostic platform. Its beachhead product, the 4D QPOR Breast, has been awarded FDA Breakthrough Device Designation for potentially improving diagnostic accuracy over the current standard of care. 4D Path was founded in 2016 by Rodrigo Navarro, Satabhisa Mukhopadhyay, and Tathagata Dasgupta.